Q3 2019: Digital health funding moderates after particularly strong first half | Rock Health

"Early public market performance for these IPOs has been mixed. As of October 1, Health Catalyst is trading about 20% below its closing price on the first day of trading after increasing more than 20% in the weeks following its public offering. Livongo’s share price fell following its first earnings report as losses were greater than analysts expected, despite 156% revenue growth that beat Wall Street estimates. Phreesia and Change..." Lire la suite